LayerBio
is a pharmaceutical company that develops and commercializes novel therapeutics for ophthalmology and orthopaedics applications... Read moreLayerBio
is a pharmaceutical company that develops and commercializes novel therapeutics for ophthalmology and orthopaedics applications... Read more
News
Dec 01, 2021
GlobalNewswire
Press Release: LayerBio : LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform
Jul 01, 2020
ePRNews
Press Release: LayerBio : LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing for Cataract Surgery
May 08, 2018
BioPortfolio
LayerBio: LayerBio Awarded $1.2 Million from NIH to Develop SustainedRelease Glaucoma Drug
Apr 27, 2018
PRcom
Press Release: LayerBio : LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO
Dec 18, 2014
PRWEB
Press Release: LayerBio : LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery
Dec 18, 2014
BIOPORTFOLIO
LayerBio: LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery
Dec 12, 2014
BIOPORTFOLIO
LayerBio: MIT Spinoff Receives NSF Grant to Develop Nanoparticle Glaucoma Therapy
Dec 12, 2014
PRWEB
Press Release: LayerBio : MIT Spinoff Receives NSF Grant to Develop Nanoparticle Glaucoma Therapy
Jul 30, 2014
FINSMEs
LayerBio: LayerBio Completes First Seed Financing
Jul 30, 2014
PRWEB
Press Release: LayerBio : MIT Spinoff LayerBio Completes Seed Round; Initiates Development of First Ophthalmology Product
LayerBio Competitors
1
2
3
4
5
6
7
8
9
10